Back to Companies
Roivant Sciences Ltd.
ROIVNasdaqCIK: 0001635088
Roivant Sciences Ltd. (ROIV) shows 50 recent insider filings from 13 insiders, with all of them on the sell side. With $0 in purchases and $397.9M in sales, the recent tape is heavily weighted toward selling (net sales of $397.9M). Torti Frank (President and Vant Chair) is the most active by dollar volume, and the single largest transaction was $105.1M by Torti Frank. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$482.3M
Purchases
$0
Sales
$397.9M
Unique Insiders
13
Recent Insider Trades
50 loaded
| Sep 14 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, | Director | Tax withheld | $89.2K |
| Sep 14 | ROIV Roivant Sciences Ltd. | MOMTAZEE JAMES C | Director | Tax withheld | $118.9K |
| Sep 14 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen | Insider | Tax withheld | $210.1K |
| Sep 14 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Tax withheld | $71.4K |
| Sep 14 | ROIV Roivant Sciences Ltd. | Oren Ilan | Director | Tax withheld | $97.4K |
| Sep 10 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Insider | Sell | $798.0K |
| Sep 1 | ROIV Roivant Sciences Ltd. | Venker Eric | Insider | Sell | $7.2M |
| Aug 24 | ROIV Roivant Sciences Ltd. | Pulik Richard | Insider | Tax withheld | $211.8K |
| Aug 24 | ROIV Roivant Sciences Ltd. | Venker Eric | Insider | Tax withheld | $512.4K |
| Aug 21 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh | Insider | Sell | $12.4M |
| Aug 18 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh | Insider | Sell | $24.2M |
| Jul 29 | ROIV Roivant Sciences Ltd. | Venker Eric | Insider | Sell | $7.0M |
| Jul 21 | ROIV Roivant Sciences Ltd. | MOMTAZEE JAMES C | Insider | Grant | $0 |
| Jul 21 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, | Insider | Grant | $0 |
| Jul 21 | ROIV Roivant Sciences Ltd. | Oren Ilan | Insider | Grant | $0 |
| Jul 2 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Tax withheld | $2.7M |
| Jul 2 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh | President & CIO, Director | Tax withheld | $1.7M |
| Jul 2 | ROIV Roivant Sciences Ltd. | Torti Frank | President and Vant Chair | Tax withheld | $1.4M |
| Jul 2 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Sell | $349.0K |
| Jul 1 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, | Director | Sell | $610.3K |
| Jun 30 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen | Insider | Sell | $49.4M |
| Jun 30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S | Insider | Sell | $56.4M |
| Jun 30 | ROIV Roivant Sciences Ltd. | QVT Financial LP | Insider | Sell | $49.4M |
| Jun 29 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh | President & CIO, Director | Sell | $34.1M |
| Jun 26 | ROIV Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Sell | $6.6M |
| Jun 23 | ROIV Roivant Sciences Ltd. | Humes Jennifer | Chief Accounting Officer | Tax withheld | $112.6K |
| Jun 23 | ROIV Roivant Sciences Ltd. | Pulik Richard | CFO | Tax withheld | $66.9K |
| May 22 | ROIV Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Sell | $6.1M |
| May 22 | ROIV Roivant Sciences Ltd. | Pulik Richard | CFO | Tax withheld | $614.6K |
| Apr 22 | ROIV Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Sell | $5.9M |
| Apr 22 | ROIV Roivant Sciences Ltd. | Humes Jennifer | Chief Accounting Officer | Grant | $789.7K |
| Apr 22 | ROIV Roivant Sciences Ltd. | Pulik Richard | CFO | Grant | $2.4M |
| Apr 21 | ROIV Roivant Sciences Ltd. | MOMTAZEE JAMES C | Director | Grant | $2.8K |
| Apr 21 | ROIV Roivant Sciences Ltd. | Oren Ilan | Insider | Grant | $2.8K |
| Apr 21 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, | Director | Grant | $0 |
| Apr 20 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Sell | $8.4M |
| Apr 10 | ROIV Roivant Sciences Ltd. | Humes Jennifer | Insider | Sell | $384.1K |
| Apr 2 | ROIV Roivant Sciences Ltd. | Torti Frank | President and Vant Chair | Tax withheld | $4.4M |
| Apr 1 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Exercise | $9.9M |
| Apr 1 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh | President & CIO, Director | Exercise | $6.0M |
| Mar 30 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Insider | Sell | $1.9M |
| Mar 24 | ROIV Roivant Sciences Ltd. | Humes Jennifer | Chief Accounting Officer | Tax withheld | $402.4K |
| Mar 24 | ROIV Roivant Sciences Ltd. | Pulik Richard | CFO | Tax withheld | $42.8K |
| Mar 19 | ROIV Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Sell | $5.6M |
| Mar 18 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, | Director | Sell | $1.2M |
| Feb 24 | ROIV Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Tax withheld | $191.4K |
| Feb 24 | ROIV Roivant Sciences Ltd. | Pulik Richard | CFO | Tax withheld | $27.1K |
| Feb 23 | ROIV Roivant Sciences Ltd. | Torti Frank | President and Vant Chair | Sell | $82.0M |
| Feb 18 | ROIV Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Sell | $5.3M |
| Feb 13 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen | Insider | Sell | $32.7M |
50 filings+